{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T07:31:08Z","timestamp":1753601468165},"reference-count":22,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2018]]},"DOI":"10.7883\/yoken.jjid.2017.458","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T22:25:19Z","timestamp":1524781519000},"page":"229-233","source":"Crossref","is-referenced-by-count":11,"title":["A Novel System for Constructing a Recombinant Highly-Attenuated Vaccinia Virus Strain (LC16m8) Expressing Foreign Genes and Its Application for the Generation of LC16m8-Based Vaccines against Herpes Simplex Virus 2"],"prefix":"10.7883","volume":"71","author":[{"given":"Natsumi","family":"Omura","sequence":"first","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"},{"name":"Department of Life Science and Medical Bioscience, Waseda University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Shibamura","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"},{"name":"Department of Life Science and Medical Bioscience, Waseda University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Egawa","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruko","family":"Takeyama","sequence":"additional","affiliation":[{"name":"Department of Life Science and Medical Bioscience, Waseda University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Smith GL, Murphy BR, Moss B. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci USA. 1983;80:7155-9.","DOI":"10.1073\/pnas.80.23.7155"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lorenzo MM, Galindo I, Blasco R. Construction and isolation of recombinant vaccinia virus using genetic markers. Methods Mol Biol 2004;269:15-30.","DOI":"10.1385\/1-59259-789-0:015"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Scheiflinger F, Dorner F, Falkner FG. Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus. Arch Virol. 1998;143:467-74.","DOI":"10.1007\/s007050050303"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cao JX, Upton C. gpt-gus fusion gene for selection and marker in recombinant poxviruses. Biotechniques. 1997;22:276-8.","DOI":"10.2144\/97222bm17"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Popov S, Mirshahidi S, Essono S, et al. Generation of recombinant vaccinia viruses via green fluorescent protein selection. DNA Cell Biol. 2009;28:103-8.","DOI":"10.1089\/dna.2008.0792"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kenner J, Cameron F, Empig C, et al. LC16m8: an attenuated smallpox vaccine. Vaccine. 2006;24:7009-22.","DOI":"10.1016\/j.vaccine.2006.03.087"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Felman YM, Nikitas JA. Sexually transmitted diseases and child sexual abuse. Part II. N Y State J Med. 1983;83:714-6.","DOI":"10.1016\/S0022-5347(17)51651-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med. 2012;366:34-43.","DOI":"10.1056\/NEJMoa1103151"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Morikawa S, Sakiyama T, Hasegawa H, et al. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection. J Virol. 2005;79:11873-91.","DOI":"10.1128\/JVI.79.18.11873-11891.2005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Saijo M, Suzutani T, De Clercq E, et al. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain. Antiviral Res. 2002;56:253-62.","DOI":"10.1016\/S0166-3542(02)00131-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chakrabarti S, Sisler JR, Moss B. Compact, synthetic, vaccinia virus early\/late promoter for protein expression. Biotechniques. 1997;23:1094-7.","DOI":"10.2144\/97236st07"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zawatzky R, Gresser I, DeMaeyer E, et al. The role of interferon in the resistance of C57BL\/6 mice to various doses of herpes simplex virus type 1. J Infect Dis. 1982;146:405-10.","DOI":"10.1093\/infdis\/146.3.405"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kidokoro M, Tashiro M, Shida H. Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8. Proc Natl Acad Sci USA. 2005;102:4152-7.","DOI":"10.1073\/pnas.0406671102"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Walsh SR, Dolin R. Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Rev Vaccines. 2011;10:1221-40.","DOI":"10.1586\/erv.11.79"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fleck M, Podlech J, Weise K, et al. A vaccinia virus\u2013herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB\/c mice. Med Microbiol Immunol. 1994;183:87-94.","DOI":"10.1007\/BF00277159"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cremer KJ, Mackett M, Wohlenberg C, et al. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science. 1985;228:737-40.","DOI":"10.1126\/science.2986288"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rooney JF, Wohlenberg CR, Moss B, et al. Live vaccinia virus recombinants expressing herpes simplex virus genes. Rev Infect Dis. 1991;13 Suppl 11:S898-903.","DOI":"10.1093\/clind\/13.Supplement_11.S898"},{"key":"18","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0264-410X(99)00416-8","volume":"18","year":"2000","unstructured":"18. Bernstein DI. Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection. Vaccine. 2000;18:1351-8.","journal-title":"Vaccine","ISSN":"http:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Belyakov IM, Earl P, Dzutsev A, et al. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci USA. 2003;100:9458-63.","DOI":"10.1073\/pnas.1233578100"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 2004;428:182-5.","DOI":"10.1038\/nature02331"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wyatt LS, Earl PL, Eller LA, et al. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci USA. 2004;101:4590-5.","DOI":"10.1073\/pnas.0401165101"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Geurs TL, Hill EB, Lippold DM, et al. Sex differences in murine susceptibility to systemic viral infections. J Autoimmun. 2012;38:J245-53.","DOI":"10.1016\/j.jaut.2011.12.003"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/71\/3\/71_JJID.2017.458\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T04:06:05Z","timestamp":1571285165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/71\/3\/71_JJID.2017.458\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2017.458","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}